-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 15th, Joincare announced that Livzon Pharmaceutical Factory, a wholly-owned subsidiary, received the "Drug Supplement Application Approval Notice" approved and issued by the National Medical Products Administration.
Omeprazole sodium for injection is a category B product in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog" (Yibaofa [2020] No.
As of the disclosure date of this announcement, the cumulative direct R&D expenses for the consistency evaluation of omeprazole sodium for injection have been approximately RMB 5,471,100